These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34179513)

  • 1. Efficacy and safety of vasopressin and terlipressin in preterm neonates: a protocol for a systematic review.
    Alsaadi AS; Sushko K; Bui V; Van Den Anker J; Razak A; Samiee-Zafarghandy S
    BMJ Paediatr Open; 2021; 5(1):e001067. PubMed ID: 34179513
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and Safety of Vasopressin and Terlipressin in Preterm Neonates: A Systematic Review.
    Al-Saadi A; Sushko K; Bui V; van den Anker J; Razak A; Samiee-Zafarghandy S
    Int J Environ Res Public Health; 2022 Oct; 19(21):. PubMed ID: 36360641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of low-dose versus high-dose hydrocortisone to treat hypotension in neonates: a protocol for a systematic review and meta-analysis.
    Sushko K; Al-Rawahi N; Watterberg K; Van Den Anker J; Litalien C; Lacroix J; Razak A; Samiee-Zafarghandy S
    BMJ Paediatr Open; 2021 Dec; 5(1):. PubMed ID: 35404836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vasopressin and its analogues for the treatment of refractory hypotension in neonates.
    Shivanna B; Rios D; Rossano J; Fernandes CJ; Pammi M
    Cochrane Database Syst Rev; 2013 Mar; (3):CD009171. PubMed ID: 23543571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of vasopressin and terlipressin in refractory shock compared to conventional therapy in the neonatal and pediatric population: a systematic review, meta-analysis, and trial sequential analysis.
    Masarwa R; Paret G; Perlman A; Reif S; Raccah BH; Matok I
    Crit Care; 2017 Jan; 21(1):1. PubMed ID: 28057037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vasopressin and terlipressin in adult vasodilatory shock: a systematic review and meta-analysis of nine randomized controlled trials.
    Serpa Neto A; Nassar AP; Cardoso SO; Manetta JA; Pereira VG; Espósito DC; Damasceno MC; Russell JA
    Crit Care; 2012 Aug; 16(4):R154. PubMed ID: 22889256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Terlipressin versus other vasoactive drugs for hepatorenal syndrome.
    Israelsen M; Krag A; Allegretti AS; Jovani M; Goldin AH; Winter RW; Gluud LL
    Cochrane Database Syst Rev; 2017 Sep; 9(9):CD011532. PubMed ID: 28953318
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic applications of vasopressin in pediatric patients.
    Agrawal A; Singh VK; Varma A; Sharma R
    Indian Pediatr; 2012 Apr; 49(4):297-305. PubMed ID: 22565074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasopressin and terlipressin in neonates and children with refractory septic shock.
    Biban P; Gaffuri M
    Curr Drug Metab; 2013 Feb; 14(2):186-92. PubMed ID: 23439212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arginine vasopressin vs. terlipressin in the treatment of shock states.
    Singer M
    Best Pract Res Clin Anaesthesiol; 2008 Jun; 22(2):359-68. PubMed ID: 18683481
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Terlipressin: vasopressin analog and novel drug for septic shock.
    Pesaturo AB; Jennings HR; Voils SA
    Ann Pharmacother; 2006 Dec; 40(12):2170-7. PubMed ID: 17148649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Terlipressin in hepatorenal syndrome.
    Mazur JE; Cooper TB; Dasta JF
    Ann Pharmacother; 2011 Mar; 45(3):380-7. PubMed ID: 21386023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasopressin in hemorrhagic shock: a systematic review and meta-analysis of randomized animal trials.
    Cossu AP; Mura P; De Giudici LM; Puddu D; Pasin L; Evangelista M; Xanthos T; Musu M; Finco G
    Biomed Res Int; 2014; 2014():421291. PubMed ID: 25254206
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vasopressin in catecholamine-refractory shock in children.
    Meyer S; Gortner L; McGuire W; Baghai A; Gottschling S
    Anaesthesia; 2008 Mar; 63(3):228-34. PubMed ID: 18081903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of vasopressin and its analogues on the liver and its disorders in the critically ill.
    Asfar P; Radermacher P; Calès P; Oberti F
    Curr Opin Crit Care; 2010 Apr; 16(2):148-52. PubMed ID: 20019608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vasopressin vs. terlipressin in the treatment of cardiovascular failure in sepsis.
    Lange M; Ertmer C; Westphal M
    Intensive Care Med; 2008 May; 34(5):821-32. PubMed ID: 18066524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vasopressin analogues in the treatment of shock states: potential pitfalls.
    Ertmer C; Rehberg S; Westphal M
    Best Pract Res Clin Anaesthesiol; 2008 Jun; 22(2):393-406. PubMed ID: 18683484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Terlipressin for acute esophageal variceal hemorrhage.
    Ioannou G; Doust J; Rockey DC
    Cochrane Database Syst Rev; 2003; (1):CD002147. PubMed ID: 12535432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Efficacy of Terlipressin in Pediatric Distributive Shock: A Retrospective Analysis in 20 Children.
    Michel J; Hofbeck M; Spiller G; Renk H; Kumpf M; Neunhoeffer F
    Paediatr Drugs; 2017 Feb; 19(1):35-41. PubMed ID: 27766555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.